Global Cryopreserved Hepatocytes Market Insights, Forecast to 2034
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Cryopreserved Hepatocytes Market Insights, Forecast to 2034
Cryopreserved hepatocytes as an in vitro tool for generating physiologically relevant results
Global Cryopreserved Hepatocytes market is expected to reach to US$ 595 million in 2023, with a positive growth of %, compared with US$ 565 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Cryopreserved Hepatocytes industry is evaluated to reach US$ 797.4 million in 2033. The CAGR will be 5.0% during 2023 to 2033.
Globally, Cryopreserved Hepatocytes key manufacturers include Corning, Thermo Fisher Scientific, Tocris Bioscience, LONZA, Cytes Biotechnologies, BioIVT, XenoTech, Sunncell and Atlantis Bioscience Pte Ltd, etc. Corning, Thermo Fisher Scientific, Tocris Bioscience are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Cryopreserved Hepatocytes were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the sales share will be % in 2033. Moreover, China, plays a key role in the whole Cryopreserved Hepatocytes market and estimated to attract more attentions from industry insiders and investors.
Cryopreserved Hepatocytes can be divided into Human Hepatocytes and Animal Liver Cells, etc. Human Hepatocytes is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2033.
Cryopreserved Hepatocytes is widely used in various fields, such as Cell/Molecular Biology, Virology and Other,, etc. Cell/Molecular Biology provides greatest supports to the Cryopreserved Hepatocytes industry development. In 2022, global % sales of Cryopreserved Hepatocytes went into Cell/Molecular Biology filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Cryopreserved Hepatocytes market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Cryopreserved Hepatocytes market with multiple angles. Items like regional sales, revenue from 2018 to 2033 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
Corning
Thermo Fisher Scientific
Tocris Bioscience
LONZA
Cytes Biotechnologies
BioIVT
XenoTech
Sunncell
Atlantis Bioscience Pte Ltd
PRIMACYT Cell Culture Technology GmbH
Discovery
MB Biosciences
Segment by Type
Human Hepatocytes
Animal Liver Cells
Cell/Molecular Biology
Virology
Other
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2033
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Cryopreserved Hepatocytes plant distribution, commercial date of Cryopreserved Hepatocytes, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2033 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2033 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2033 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2033 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2033 in China. Product sales and revenue analysis of China from 2018 to 2033
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Cryopreserved Hepatocytes introduction, etc. Cryopreserved Hepatocytes Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14MRAResearch’s Conclusions of Cryopreserved Hepatocytes
Chapter 15Methodology and Data Sources adopted by MRAResearch
Global Cryopreserved Hepatocytes market is expected to reach to US$ 595 million in 2023, with a positive growth of %, compared with US$ 565 million in 2022 which suffered dual impact of COVID-19 and Russia-Ukraine War in the year. Backed with the increasing demand from downstream industries, Cryopreserved Hepatocytes industry is evaluated to reach US$ 797.4 million in 2033. The CAGR will be 5.0% during 2023 to 2033.
Globally, Cryopreserved Hepatocytes key manufacturers include Corning, Thermo Fisher Scientific, Tocris Bioscience, LONZA, Cytes Biotechnologies, BioIVT, XenoTech, Sunncell and Atlantis Bioscience Pte Ltd, etc. Corning, Thermo Fisher Scientific, Tocris Bioscience are top 3 players and held % sales share in total in 2022.
When considering the consumption regions, % volume of Cryopreserved Hepatocytes were sold to North America, Europe and Asia Pacific in 2022. Asia Pacific is estimated to experience fast growth, with the CAGR of % during 2023 to 2033 and the sales share will be % in 2033. Moreover, China, plays a key role in the whole Cryopreserved Hepatocytes market and estimated to attract more attentions from industry insiders and investors.
Cryopreserved Hepatocytes can be divided into Human Hepatocytes and Animal Liver Cells, etc. Human Hepatocytes is the mainstream product in the market, accounting for % sales share globally in 2022 and the proportion will be % in 2033.
Cryopreserved Hepatocytes is widely used in various fields, such as Cell/Molecular Biology, Virology and Other,, etc. Cell/Molecular Biology provides greatest supports to the Cryopreserved Hepatocytes industry development. In 2022, global % sales of Cryopreserved Hepatocytes went into Cell/Molecular Biology filed and the proportion will reach to % in 2033.
Report Covers
This report presents an overview of global Cryopreserved Hepatocytes market from 2018 to 2033, aiming to help readers to get a comprehensive understanding of global Cryopreserved Hepatocytes market with multiple angles. Items like regional sales, revenue from 2018 to 2033 and manufacturers’ sales, price, revenue and gross margin from 2018 to 2023 are analyzed. In addition, sales and revenue of product type and application in each region from 2018 to 2033 are also highlighted.
Manufacturers, Type, Application and Regions Listed in the Report
By Company
Corning
Thermo Fisher Scientific
Tocris Bioscience
LONZA
Cytes Biotechnologies
BioIVT
XenoTech
Sunncell
Atlantis Bioscience Pte Ltd
PRIMACYT Cell Culture Technology GmbH
Discovery
MB Biosciences
Segment by Type
Human Hepatocytes
Animal Liver Cells
Segment by Application
Cell/Molecular Biology
Virology
Other
Segment by Region
US & Canada
U.S.
Canada
China
Asia (excluding China)
Japan
South Korea
China Taiwan
Southeast Asia
India
Europe
Germany
France
U.K.
Italy
Russia
Latin America, Middle East & Africa
Brazil
Mexico
Turkey
Israel
GCC Countries
Chapter Outline
Chapter 1Product definition, type and application introduction
Chapter 2Regional revenue and sales volume analysis from 2018 to 2033
Chapter 3Manufacturers’ sales, revenue and price analysis, including manufacturers’ Cryopreserved Hepatocytes plant distribution, commercial date of Cryopreserved Hepatocytes, product type offered, Mergers & Acquisitions and expansion activities.
Chapter 4Product sales, revenue and price analysis by type from 2018 to 2033 globally
Chapter 5Product sales, revenue and price analysis by application from 2018 to 2033 globally
Chapter 6Product sales, revenue analysis by type and application from 2018 to 2033 in US & Canada. Product sales and revenue analysis of each country in US & Canada from 2018 to 2033
Chapter 7Product sales, revenue analysis by type and application from 2018 to 2033 in Europe. Product sales and revenue analysis of each country in Europe from 2018 to 2033
Chapter 8Product sales, revenue analysis by type and application from 2018 to 2033 in China. Product sales and revenue analysis of China from 2018 to 2033
Chapter 9Product sales, revenue analysis by type and application from 2018 to 2033 in Asia (excluding China). Product sales and revenue analysis of each country in Asia (excluding China) from 2018 to 2033
Chapter 10Product sales, revenue analysis by type and application from 2018 to 2033 in Middle East, Africa and Latin America. Product sales and revenue analysis of each country in Middle East, Africa and Latin America from 2018 to 2033.
Chapter 11Manufacturers’ outline, covering company’s basic information, major business, Cryopreserved Hepatocytes introduction, etc. Cryopreserved Hepatocytes Sales, Revenue, Price and Gross Margin of each company from 2018 to 2023
Chapter 12Industry chain analysis, like raw materials, manufacturing cost. Market channel, distributors and customers analysis
Chapter 13Market opportunities and challenges analysis
Chapter 14MRAResearch’s Conclusions of Cryopreserved Hepatocytes
Chapter 15Methodology and Data Sources adopted by MRAResearch